TY - JOUR
T1 - High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery
AU - Schäfer, Andreas
AU - Alasnag, Mirvat
AU - Giacoppo, Daniele
AU - Collet, Carlos
AU - Rudolph, Tanja K.
AU - Roguin, Ariel
AU - Buszman, Piotr P.
AU - Colleran, Roisin
AU - Stefanini, Giulio
AU - Lefèvre, Thierry
AU - Van Mieghem, Nicolas
AU - Cayla, Guillaume
AU - Naber, Christoph
AU - Baumbach, Andreas
AU - Witkowski, Adam
AU - Burzotta, Francesco
AU - Capodanno, Davide
AU - Dudek, Dariusz
AU - Al-Lamee, Rasha
AU - Banning, Adrian
AU - Maccarthy, Philip
AU - Gottardi, Roman
AU - Schoenhoff, Florian S.
AU - Czerny, Martin
AU - Thielmann, Matthias
AU - Werner, Nikos
AU - Tarantini, Giuseppe
PY - 2025
Y1 - 2025
N2 - This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG − which overall is the guideline-recommended option for revascularisation in these patients − is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and noninvasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.
AB - This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG − which overall is the guideline-recommended option for revascularisation in these patients − is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and noninvasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.
KW - complex coronary artery disease
KW - high-risk percutaneous coronary artery intervention
KW - mechanical circulatory support
KW - microaxial flow pumps
KW - reduced heart failure
KW - surgical ineligibility
KW - complex coronary artery disease
KW - high-risk percutaneous coronary artery intervention
KW - mechanical circulatory support
KW - microaxial flow pumps
KW - reduced heart failure
KW - surgical ineligibility
UR - http://hdl.handle.net/10807/306684
U2 - 10.4244/EIJ-D-23-01100
DO - 10.4244/EIJ-D-23-01100
M3 - Article
SN - 1969-6213
VL - 21
SP - 22
EP - 342
JO - EuroIntervention
JF - EuroIntervention
ER -